Corporate Counsel: Pharma, Biotech IP Counsel Expect a Litigious Year

Originally Published in Corporate Counsel | March 14, 2013 | By Lisa Shuchman

Nearly half of the chief IP counsel working in the pharmaceutical and biotech industries who participated in a new survey indicated that their companies are currently involved in patent infringement litigation—and 43 percent said there was a “very high” likelihood that they would file a claim for patent infringement in the year ahead.

See full article here.